PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ELAN vs. ZTS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ELAN and ZTS is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.4

Performance

ELAN vs. ZTS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Elanco Animal Health Incorporated (ELAN) and Zoetis Inc. (ZTS). The values are adjusted to include any dividend payments, if applicable.

-25.00%-20.00%-15.00%-10.00%-5.00%0.00%5.00%10.00%SeptemberOctoberNovemberDecember2025February
-22.90%
-14.31%
ELAN
ZTS

Key characteristics

Sharpe Ratio

ELAN:

-0.63

ZTS:

-0.56

Sortino Ratio

ELAN:

-0.76

ZTS:

-0.66

Omega Ratio

ELAN:

0.89

ZTS:

0.92

Calmar Ratio

ELAN:

-0.43

ZTS:

-0.35

Martin Ratio

ELAN:

-1.24

ZTS:

-1.11

Ulcer Index

ELAN:

23.87%

ZTS:

12.69%

Daily Std Dev

ELAN:

47.08%

ZTS:

24.85%

Max Drawdown

ELAN:

-78.00%

ZTS:

-46.52%

Current Drawdown

ELAN:

-69.17%

ZTS:

-34.77%

Fundamentals

Market Cap

ELAN:

$5.60B

ZTS:

$74.41B

EPS

ELAN:

$0.41

ZTS:

$5.23

PE Ratio

ELAN:

27.61

ZTS:

30.12

PEG Ratio

ELAN:

1.84

ZTS:

2.57

Total Revenue (TTM)

ELAN:

$3.42B

ZTS:

$9.26B

Gross Profit (TTM)

ELAN:

$1.65B

ZTS:

$6.47B

EBITDA (TTM)

ELAN:

$1.28B

ZTS:

$3.92B

Returns By Period

In the year-to-date period, ELAN achieves a -6.52% return, which is significantly lower than ZTS's -3.67% return.


ELAN

YTD

-6.52%

1M

-5.82%

6M

-22.89%

1Y

-30.34%

5Y*

-17.90%

10Y*

N/A

ZTS

YTD

-3.67%

1M

-5.39%

6M

-14.31%

1Y

-16.05%

5Y*

2.55%

10Y*

14.00%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ELAN vs. ZTS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ELAN
The Risk-Adjusted Performance Rank of ELAN is 1515
Overall Rank
The Sharpe Ratio Rank of ELAN is 1414
Sharpe Ratio Rank
The Sortino Ratio Rank of ELAN is 1414
Sortino Ratio Rank
The Omega Ratio Rank of ELAN is 1313
Omega Ratio Rank
The Calmar Ratio Rank of ELAN is 2020
Calmar Ratio Rank
The Martin Ratio Rank of ELAN is 1313
Martin Ratio Rank

ZTS
The Risk-Adjusted Performance Rank of ZTS is 1919
Overall Rank
The Sharpe Ratio Rank of ZTS is 1717
Sharpe Ratio Rank
The Sortino Ratio Rank of ZTS is 1616
Sortino Ratio Rank
The Omega Ratio Rank of ZTS is 1717
Omega Ratio Rank
The Calmar Ratio Rank of ZTS is 2424
Calmar Ratio Rank
The Martin Ratio Rank of ZTS is 1818
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ELAN vs. ZTS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Elanco Animal Health Incorporated (ELAN) and Zoetis Inc. (ZTS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ELAN, currently valued at -0.63, compared to the broader market-2.000.002.004.00-0.63-0.56
The chart of Sortino ratio for ELAN, currently valued at -0.76, compared to the broader market-6.00-4.00-2.000.002.004.006.00-0.76-0.66
The chart of Omega ratio for ELAN, currently valued at 0.89, compared to the broader market0.501.001.502.000.890.92
The chart of Calmar ratio for ELAN, currently valued at -0.43, compared to the broader market0.002.004.006.00-0.43-0.35
The chart of Martin ratio for ELAN, currently valued at -1.24, compared to the broader market0.0010.0020.0030.00-1.24-1.11
ELAN
ZTS

The current ELAN Sharpe Ratio is -0.63, which is comparable to the ZTS Sharpe Ratio of -0.56. The chart below compares the historical Sharpe Ratios of ELAN and ZTS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.00SeptemberOctoberNovemberDecember2025February
-0.63
-0.56
ELAN
ZTS

Dividends

ELAN vs. ZTS - Dividend Comparison

ELAN has not paid dividends to shareholders, while ZTS's dividend yield for the trailing twelve months is around 1.15%.


TTM20242023202220212020201920182017201620152014
ELAN
Elanco Animal Health Incorporated
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
ZTS
Zoetis Inc.
1.15%1.06%0.76%0.89%0.41%0.48%0.50%0.59%0.58%0.71%0.69%0.67%

Drawdowns

ELAN vs. ZTS - Drawdown Comparison

The maximum ELAN drawdown since its inception was -78.00%, which is greater than ZTS's maximum drawdown of -46.52%. Use the drawdown chart below to compare losses from any high point for ELAN and ZTS. For additional features, visit the drawdowns tool.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%SeptemberOctoberNovemberDecember2025February
-69.17%
-34.77%
ELAN
ZTS

Volatility

ELAN vs. ZTS - Volatility Comparison

Elanco Animal Health Incorporated (ELAN) and Zoetis Inc. (ZTS) have volatilities of 9.14% and 8.92%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%16.00%SeptemberOctoberNovemberDecember2025February
9.14%
8.92%
ELAN
ZTS

Financials

ELAN vs. ZTS - Financials Comparison

This section allows you to compare key financial metrics between Elanco Animal Health Incorporated and Zoetis Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab